Publikationen - Institut für Radiopharmazeutische Krebsforschung - Jahr 2017
16 Publikationen2017
An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment
Huebner, D.; Rieger, C.; Bergmann, R.; Ullrich, M.; Meister, S.; et al. (13 authors)
-
BMC Cancer 17(2017)1, 790
DOI: 10.1186/s12885-017-3778-3
Biological characterization of novel nitroimidazole-peptide conjugates in vitro and in vivo.
Bergmann, R.; Splith, K.; Pietzsch, J.; Bachmann, M.; Neundorf, I.
-
Journal of Peptide Science 23(2017), 597-609
DOI: 10.1002/psc.2995
Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells
Bachmann, D.; Aliperta, R.; Bergmann, R.; Feldmann, A.; Koristka, S.; et al. (19 authors)
-
Oncotarget 9(2017), 7487-7500
DOI: 10.18632/oncotarget.23556
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
Mitwasi, N.; Feldmann, A.; Bergmann, R.; Berndt, N.; Arndt, C.; et al. (17 authors)
-
Oncotarget 8(2017), 108584-108603
DOI: 10.18632/oncotarget.21017
99mTechnetium-based Small Molecule Radiopharmaceuticals and Radiotracers Targeting Inflammation and Infection
Kniess, T.; Laube, M.; Wüst, F.; Pietzsch, J.
-
Dalton Transactions 46(2017), 14435-14451
DOI: 10.1039/c7dt01735a
Preparation of a novel radiotracer targeting the EphB4 receptor via radiofluorination using spiro azetidinium salts as precursor
Wiemer, J.; Steinbach, J.; Pietzsch, J.; Mamat, C.
-
Journal of Labelled Compounds and Radiopharmaceuticals 60(2017), 489-498
DOI: 10.1002/jlcr.3526
Surface charge and particle size determine the metabolic fate of dendritic polyglycerols
Pant, K.; Pufe, J.; Zarschler, K.; Bergmann, R.; Steinbach, J.; et al. (9 authors)
-
Nanoscale 9(2017), 8723-8739
DOI: 10.1039/C7NR01702B
A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform
Albert, S.; Arndt, C.; Feldmann, A.; Bergmann, R.; Bachmann, D.; et al. (18 authors)
-
OncoImmunology 6(2017)4, e1287246
DOI: 10.1080/2162402X.2017.1287246
ISSN: 2162-402X
A novel tumor pretargeting system based on complementary L-configured oligonucleotides
Schubert, M.; Bergmann, R.; Förster, C.; Sihver, W.; Vonhoff, S.; et al. (12 authors)
-
Bioconjugate Chemistry 28(2017)4, 1176-1188
DOI: 10.1021/acs.bioconjchem.7b00045
In vivo examination of an injectable hydrogel system crosslinked by peptide-oligosaccharide interaction in immunocompetent nude mice
Tondera, C.; Wieduwild, R.; Röder, E.; Werner, C.; Zhang, Y.; et al. (6 authors)
-
Advanced Functional Materials 27(2017)15, 1605189
DOI: 10.1002/adfm.201605189
Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”
Feldmann, A.; Arndt, C.; Bergmann, R.; Loff, S.; Cartellieri, M.; et al. (20 authors)
-
Oncotarget 8(2017)19, 31368-31385
DOI: 10.18632/oncotarget.15572
The Why and How of Amino Acid Analytics in Cancer Diagnostics and Therapy
Manig, F.; Kuhne, K.; von Neubeck, C.; Schwarzenbolz, U.; Yu, Z.; et al. (8 authors)
-
Journal of Biotechnology 242(2017), 30-54
DOI: 10.1016/j.jbiotec.2016.12.001
Human endothelial cell models in biomaterial research
Hauser, S.; Jung, F.; Pietzsch, J.
-
Trends in Biotechnology 35(2017)3, 265-277
DOI: 10.1016/j.tibtech.2016.09.007
Cryogel-Supported Stem Cell Factory for Customized Sustained Release of Bispecific Antibodies for Cancer Immunotherapy
Aliperta, R.; Welzel, P. B.; Bergmann, R.; Freudenberg, R.; Berndt, N.; et al. (17 authors)
-
Scientific Reports 7(2017), 42855
DOI: 10.1038/srep42855
Insights into binding of S100 proteins to scavenger receptors: class B scavenger receptor CD36 binds S100A12 with high affinity
Tondera, C.; Laube, M.; Pietzsch, J.
-
Amino Acids 49(2017), 183-191
Online First (2016) DOI: 10.1007/s00726-016-2349-2
Jahre: 2021 2020 2019 2018 2017 2016 2015 2014 2013